These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37779027)

  • 21. Multilocus sequence analysis of Streptococcus canis confirms the zoonotic origin of human infections and reveals genetic exchange with Streptococcus dysgalactiae subsp. equisimilis.
    Pinho MD; Matos SC; Pomba C; Lübke-Becker A; Wieler LH; Preziuso S; Melo-Cristino J; Ramirez M
    J Clin Microbiol; 2013 Apr; 51(4):1099-109. PubMed ID: 23345291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Streptococcus agalactiae Isolates from Humans and Companion Animals Reveals Genotypic and Phenotypic Differences.
    Maeda T; Tsuyuki Y; Fujita T; Fukushima Y; Goto M; Yoshida H; Takahashi T
    Jpn J Infect Dis; 2020 Jul; 73(4):308-315. PubMed ID: 32009057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characterization and antibiotic resistance of clinical Streptococcus dysgalactiae subsp. equisimilis in Beijing, China.
    Lu B; Fang Y; Huang L; Diao B; Du X; Kan B; Cui Y; Zhu F; Li D; Wang D
    Infect Genet Evol; 2016 Jun; 40():119-125. PubMed ID: 26925701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathomolecular epidemiology, antimicrobial resistance, and virulence genes of Streptococcus dysgalactiae subsp. equisimilis isolates from slaughtered pigs in India.
    Patel SM; Sahoo M; Thakor JC; Murali D; Kumar P; Singh R; Singh KP; Saikumar G; Jana C; Patel SK; Mote AB; Karthikeyan R; Vandre RK; Biswal JK; Sahoo NR
    J Appl Microbiol; 2024 Jan; 135(1):. PubMed ID: 38178631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic susceptibilities, streptococcal pyrogenic exotoxin gene profiles among clinical isolates of group C or G Streptococcus dysgalactiae subsp. equisimilis & of group G S. anginosus group at a tertiary care centre.
    Behera B; Mathur P; Bhardwaj N; Jain N; Misra MC; Kapil A; Singh S
    Indian J Med Res; 2014 Mar; 139(3):438-45. PubMed ID: 24820839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of group G Streptococcus dysgalactiae subsp. equisimilis recovered from patients and healthy people in China.
    Yin J; Yu S; Liu X; Li Y; Gao W; Zhou L; Ji L; Shen X; Yang Y
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):41-6. PubMed ID: 22078907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of mitogenic activity of speG- and speG(dys)-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections.
    Brandt CM; Schweizer KG; Holland R; Lütticken R; Freyaldenhoven BS
    Int J Med Microbiol; 2005 Dec; 295(8):539-46. PubMed ID: 16325550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness.
    Pinho MD; Melo-Cristino J; Ramirez M
    J Clin Microbiol; 2006 Mar; 44(3):841-6. PubMed ID: 16517864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genogrouping of type II-A CRISPR array in Streptococcus dysgalactiae subsp. equisimilis from humans and companion animals compared to multilocus sequence and emm typing.
    Fukushima Y; Takayama Y; Yoshida H; Goto M; Tsuyuki Y; Takahashi T
    J Infect Chemother; 2022 Nov; 28(11):1571-1574. PubMed ID: 35870789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of a viridans group strain reveals a case of bacteremia due to lancefield group G alpha-hemolytic Streptococcus dysgalactiae subsp equisimilis in a patient with pyomyositis and reactive arthritis.
    Woo PC; Teng JL; Lau SK; Lum PN; Leung KW; Wong KL; Li KW; Lam KC; Yuen KY
    J Clin Microbiol; 2003 Feb; 41(2):613-8. PubMed ID: 12574255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome.
    Ikebe T; Okuno R; Sasaki M; Kanda Y; Otsuka H; Kawahara R; Ohya H; Suzuki M; Uchida K; Nihonmatsu H; Ohnishi M;
    J Infect Chemother; 2018 Feb; 24(2):117-122. PubMed ID: 29107650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group C Streptococcus dysgalactiae subsp. equisimilis in south-east Brazil: genetic diversity, resistance profile and the first report of human and equine isolates belonging to the same multilocus sequence typing lineage.
    Silva LG; Genteluci GL; Corrêa de Mattos M; Glatthardt T; Sá Figueiredo AM; Ferreira-Carvalho BT
    J Med Microbiol; 2015 May; 64(Pt 5):551-558. PubMed ID: 25752850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.
    Rantala S
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1303-10. PubMed ID: 24682845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Streptococcus pyogenes virulence genes in Streptococcus dysgalactiae subsp. equisimilis from Vellore, India.
    Babbar A; Itzek A; Pieper DH; Nitsche-Schmitz DP
    Folia Microbiol (Praha); 2018 Sep; 63(5):581-586. PubMed ID: 29532420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the Genomics and Mouse Virulence of an Emergent Clone of Streptococcus dysgalactiae Subspecies
    Beres SB; Olsen RJ; Long SW; Eraso JM; Boukthir S; Faili A; Kayal S; Musser JM
    Microbiol Spectr; 2023 Mar; 11(2):e0455022. PubMed ID: 36971562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.
    Pinho MD; Melo-Cristino J; Ramirez M;
    Antimicrob Agents Chemother; 2010 May; 54(5):1769-77. PubMed ID: 20145082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence diversity of sicG among group C and G Streptococcus dysgalactiae subspecies equisimilis isolates associated with human infections in western Norway.
    Oppegaard O; Mylvaganam H; Skrede S; Langeland N; Kittang BR
    Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):273-7. PubMed ID: 24019161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
    Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
    Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Characterization of Invasive Streptococcus dysgalactiae subsp. equisimilis, Japan.
    Wajima T; Morozumi M; Hanada S; Sunaoshi K; Chiba N; Iwata S; Ubukata K
    Emerg Infect Dis; 2016 Feb; 22(2):247-54. PubMed ID: 26760778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Species Identification of β-Hemolytic Streptococci from Diseased Companion Animals and Their Antimicrobial Resistance Data in Japan (2017).
    Fukushima Y; Tsuyuki Y; Goto M; Yoshida H; Takahashi T
    Jpn J Infect Dis; 2019 Mar; 72(2):94-98. PubMed ID: 30381681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.